These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10149710)

  • 1. Use of contrast media beneficial to angioplasty.
    Dawson P; Strickland N; Allison D
    Diagn Imaging (San Franc); 1991 Feb; 13(2):91-8, 146. PubMed ID: 10149710
    [No Abstract]   [Full Text] [Related]  

  • 2. Early and late ischemic complications of PTCA.
    Ferguson JJ; Wilson JM
    J Invasive Cardiol; 1994; 6 Suppl A():3A-12A, discussion 43A-45A. PubMed ID: 10155092
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous coronary intervention versus coronary-artery bypass grafting.
    Edwards JL
    N Engl J Med; 2009 Jun; 360(25):2672-3; author reply 2674-5. PubMed ID: 19537314
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular disease in diabetes.
    Malcolm J; Meggison H; Sigal R
    Clin Evid; 2002 Dec; (8):541-68. PubMed ID: 12603899
    [No Abstract]   [Full Text] [Related]  

  • 5. Landmarks: examining the foundation for GP IIb/IIIa inhibitors in PCI.
    J Invasive Cardiol; 2002 Dec; 14(12):776-9. PubMed ID: 12537005
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
    Arbab-Zadeh A
    J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
    [No Abstract]   [Full Text] [Related]  

  • 7. Hidden drugs, hidden risks--is cocaine use a new risk factor for stent thrombosis?
    Lemos PA
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):959-60. PubMed ID: 17525956
    [No Abstract]   [Full Text] [Related]  

  • 8. Clopidogrel use in diabetic patients with new stents.
    Cardiovasc J Afr; 2008; 19(4):232. PubMed ID: 18776976
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular disease in diabetes.
    Sigal R; Malcolm J; Meggison H
    Clin Evid; 2002 Jun; (7):498-520. PubMed ID: 12230676
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimized combination of antiplatelet treatment and anticoagulation for percutaneous coronary intervention: the final word is not out yet!
    Gruberg L; Beyar R
    J Invasive Cardiol; 2002 May; 14(5):251-3. PubMed ID: 11983946
    [No Abstract]   [Full Text] [Related]  

  • 11. Hazard--the anticoagulation bridge or just go transradial.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):48-9. PubMed ID: 19089937
    [No Abstract]   [Full Text] [Related]  

  • 12. Multivessel coronary artery disease: how do we treat it?
    Sharma S
    Timely Top Med Cardiovasc Dis; 2007 Jul; 11():E15. PubMed ID: 18297143
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
    Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
    Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombogenicity in patients with percutaneous coronary artery intervention and dual antiplatelet treatment.
    Kamphuisen PW
    Eur Heart J; 2008 Jul; 29(14):1699-700. PubMed ID: 18544543
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter regarding article by Hlatky et al, "medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease".
    Osman F; Qaisar S; Pitt M
    Circulation; 2005 Apr; 111(13):e176-7; author reply e176-7. PubMed ID: 15811864
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events.
    Bhatt DL
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():3B-9B; discussion 9B-10B. PubMed ID: 12724580
    [No Abstract]   [Full Text] [Related]  

  • 18. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.
    Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR
    J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in post stenting medication protocol.
    Morice MC
    J Invasive Cardiol; 1995; 7 Suppl A():32A-35A. PubMed ID: 10155114
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
    Bhatt DL
    Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.